Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 May 1;54(3):686-9.
doi: 10.3349/ymj.2013.54.3.686.

Studies on therapeutic effects and pathological features of an antithrombin preparation in septic disseminated intravascular coagulation patients

Yuichiro Sakamoto  1 , Satoshi Inoue, Takashi Iwamura, Tomoko Yamashita, Atsushi Nakashima, Yoichi Nishimura, Hiroyuki Koami, Hisashi Imahase, Akiko Goto, Kosuke Chris Yamada, Kunihiro Mashiko, Hiroyuki Yokota
Affiliations

Studies on therapeutic effects and pathological features of an antithrombin preparation in septic disseminated intravascular coagulation patients

Yuichiro Sakamoto et al. Yonsei Med J. .

Abstract

Purpose: Few reports have been made on the therapeutic effects as well as pathological features of an antithrombin preparation in patients diagnosed with septic disseminated intravascular coagulation (DIC) by the diagnostic criteria for acute DIC.

Materials and methods: A total of 88 sepsis patients who had received inpatient hospital care during the period from January 2000 through December 2008 were divided into two groups, an antithrombin group and a non-antithrombin group, to study the outcomes. Furthermore, the relationship between sepsis-related factors and DIC in 44 patients was studied.

Results: The antithrombin group contained 34 patients, and the non-antithrombin group contained 54 patients. The outcomes were significantly better in the antithrombin group. The levels of protein C were low in DIC patients.

Conclusion: Our results suggest that early administration of antithrombin might improve outcomes of septic DIC patients in the diagnostic criteria for Japanese Association for Acute Medicine acute DIC.

Keywords: Antithrombin; DIC; sepsis.

PubMed Disclaimer

Conflict of interest statement

The authors have no financial conflicts of interest.

Figures

Fig. 1
Fig. 1
Survival rate. Among sepsis patients, outcomes in the AT-III group were significantly better (p=0.0066). AT, antithrombin.
Fig. 2
Fig. 2
Survival rate in septic DIC cases. Among septic DIC patients, outcomes in the AT-III group were significantly better (p=0.0031). AT, antithrombin; DIC, disseminated intravascular coagulation.
Fig. 3
Fig. 3
Protein C. The value of protein C was significantly low in DIC patients (p=0.0097). DIC, disseminated intravascular coagulation.
See this image and copyright information in PMC

References

    1. Kushimoto S, Gando S, Saitoh D, Ogura H, Mayumi T, Koseki K, et al. Clinical course and outcome of disseminated intravascular coagulation diagnosed by Japanese Association for Acute Medicine criteria. Comparison between sepsis and trauma. Thromb Haemost. 2008;100:1099–1105. - PubMed
    1. Petros S, Kliem P, Siegemund T, Siegemund R. Thrombin generation in severe sepsis. Thromb Res. 2012;129:797–800. - PubMed
    1. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004;32:858–873. - PubMed
    1. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008;36:296–327. - PubMed
    1. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001;344:699–709. - PubMed

Substances